Table 2. Main features of the 14... | American Society of Hematology

Table 2.

Main features of the 14 patients with HIT

				Previous heparin exposure
Patient no.	Age, y	Sex	Cancer present	Previous exposure	Time since exposure	Setting	Drug	Dosage	Time to HIT, d	Platelet count, × 10⁹/L, baseline/nadir	IgG ELISA OD	HIPA	TE	Time to TE d
1	73	M	Yes	Yes	4 mo	In hospital	Nadroparin	High	5	259/127	0.8	Negative	No	NA
2	26	M	Yes	No	NA	In hospital	Nadroparin	High	7	249/18	1.3	Positive	No	NA
3	74	M	No	Yes	2 y	In hospital	Nadroparin	High	12	150/32	>2.0	Positive	TIA	14
4	84	F	Yes	Yes	5 wk	In hospital	Enoxaparin	High	2	231/83	>2.0	Positive	No	NA
5	83	F	No	Yes	5 mo	In hospital	Dalteparin	Low	5	209/68	1.8	Positive	No	NA
6	73	M	Yes	Yes	6 mo	In hospital	Nadroparin	Intermediate	9	210/70	>2.0	Positive	Ischemic stroke	12
7	83	M	No	No	NA	In hospital	Nadroparin	Low	12	214/30	1.1	Positive	No	NA
8	63	M	No	Yes	5 mo	At home	Dalteparin	Low	5	186/50	0.9	Negative	No	NA
9	22	M	No	Yes	12 mo	At home	Enoxaparin	Intermediate	9	232/68	1.4	Positive	DVT	11
10	23	M	No	No	NA	At home	Nadroparin	Intermediate	9	248/65	1.2	Positive	No	NA
11	65	F	No	Yes	4 mo	At home	Enoxaparin	Intermediate	4	313/67	1.0	Positive	No	NA
12	44	F	No	Yes	8 mo	At home	Nadroparin	High	6	365/124	1.0	Negative	No	NA
13	38	M	No	No	NA	At home	Nadroparin	Intermediate	13	234/90	1.2	Positive	No	NA
14	72	F	No	Yes	6 mo	At home	Nadroparin	High	5	255/88	>2.0	Positive	Extension of DVT	6

				Previous heparin exposure
Patient no.	Age, y	Sex	Cancer present	Previous exposure	Time since exposure	Setting	Drug	Dosage	Time to HIT, d	Platelet count, × 10⁹/L, baseline/nadir	IgG ELISA OD	HIPA	TE	Time to TE d
1	73	M	Yes	Yes	4 mo	In hospital	Nadroparin	High	5	259/127	0.8	Negative	No	NA
2	26	M	Yes	No	NA	In hospital	Nadroparin	High	7	249/18	1.3	Positive	No	NA
3	74	M	No	Yes	2 y	In hospital	Nadroparin	High	12	150/32	>2.0	Positive	TIA	14
4	84	F	Yes	Yes	5 wk	In hospital	Enoxaparin	High	2	231/83	>2.0	Positive	No	NA
5	83	F	No	Yes	5 mo	In hospital	Dalteparin	Low	5	209/68	1.8	Positive	No	NA
6	73	M	Yes	Yes	6 mo	In hospital	Nadroparin	Intermediate	9	210/70	>2.0	Positive	Ischemic stroke	12
7	83	M	No	No	NA	In hospital	Nadroparin	Low	12	214/30	1.1	Positive	No	NA
8	63	M	No	Yes	5 mo	At home	Dalteparin	Low	5	186/50	0.9	Negative	No	NA
9	22	M	No	Yes	12 mo	At home	Enoxaparin	Intermediate	9	232/68	1.4	Positive	DVT	11
10	23	M	No	No	NA	At home	Nadroparin	Intermediate	9	248/65	1.2	Positive	No	NA
11	65	F	No	Yes	4 mo	At home	Enoxaparin	Intermediate	4	313/67	1.0	Positive	No	NA
12	44	F	No	Yes	8 mo	At home	Nadroparin	High	6	365/124	1.0	Negative	No	NA
13	38	M	No	No	NA	At home	Nadroparin	Intermediate	13	234/90	1.2	Positive	No	NA
14	72	F	No	Yes	6 mo	At home	Nadroparin	High	5	255/88	>2.0	Positive	Extension of DVT	6

ELISA indicates enzyme-linked immunosorbent assay; TE, thromboembolism; TIA, transitory ischemic attack; NA, not applicable.